In order to verify the potential of FGF13 in clinical applications, serum FGF13 protein levels in IGT and T2DM patients were detected by ELISA, and the involvement of FGF13 in the pathogenesis of diabetes was confirmed. The gene discussed is FGF13; the disease is type 2 diabetes mellitus.